Caomihe Ni Drisceoil shares how she uses CBD, alongside other natural remedies, to help combat the pain from arthritis and migraines.
Caoimhe Ni Drisceoil was diagnosed with arthritis when she was in her 50s. The pain began in her knees before moving to her hands and other joints. She also suffered from painful migraines.
“It was a gradual development over the years, to a point where it was becoming uncomfortable to do the things I loved such as gardening or walking,” she said.
Arthritis is a common condition that causes pain and inflammation in the joints. It can affect people of all ages but particularly, older people. Symptoms can include joint pain, tenderness and stiffness, inflammation and restricted movement. It is thought that over 900,000 people in Ireland live with arthritis pain.
Patients will often have to make lifestyle adjustments to help ease the pain they experience. Caoimhe learned to avoid causing extra pressure on her joints if the pain was particularly bad, but she also struggled to fall asleep.
“If I was having a bad day then I wouldn’t stress the area that was inflamed. I would break up what I was doing during the day to relieve the pressure on that area and go back to it again if the pain eased off or I would take medication in the evening,” she said.
“Sometimes it would stop me from sleeping which is difficult for your physical and mental health, as well as not being able to do things you love. It’s also stopped me from learning a musical instrument which was on my bucket list. I haven’t been able to do this because of the joints in my hands being too painful.”
Natural arthritis pain relief
Caoimhe has always been a big believer in natural remedies or homoeopathic alternatives. She often took echinacea for colds or flu. When she began researching pain relief, she looked for the natural options first.
She explained: “I started off with glucosamine and chlondroitin first, they are herbal remedies that you can get over the counter to ease the joints. Glucosamine and vitamins help the cartilage around the joints. The chlondroitin helps the glucose absorb into your body quicker. I was on that for several years while adding paracetamol if I knew I wasn’t going to be able to sleep from it.”
Caomihe had been experiencing migraine pain at the same time, and was struggling to find a pain relief option that helped her with both. As her doctor prescribed pain relief, she began to explore if CBD could offer an alternative.
“I was on half beta-blockers for over a year and they weren’t stopping me from getting the migraines,” she said.
“My doctors wanted to increase the pain relief and I wasn’t happy with that which is why I started taking CBD,” she said. “They were daily headaches that were very uncomfortable. It would make me miserable and stop me from going out.”
CBD for arthritis
Caomihe began to take CBD drops in the morning. She describes experiencing the effects “almost immediately” on her migraines. However, when it came to arthritis pain, it took further lifestyle changes.
“I noticed that once I was on it, I didn’t get full-blown migraines. I would get headaches, but they never developed into migraine symptoms. I wouldn’t get the tingling in the arms or the tongue, the brain fog or lose the ability to think clearly. It would just be a normal headache,” she said.
Caoimhe found that CBD was just part of the many different things she could do to fight the pain rather than a cure for everything. She combined her CBD intake with dietary changes. One of her daughters is a personal trainer who was able to design a diet plan with pain relief in mind.
She said: “There are things that flare up inflammation in the body such as bell peppers, aubergines. Those [can be] bad if you are prone to inflammation so I avoided those, added more protein for energy and stopped eating gluten as a personal preference. I also gave up red wine, chocolate and cheese as they were triggers for my headaches.”
She also started to combine the CBD with ginger and turmeric which are also known for their anti-inflammatory properties.
“It’s part of a whole collection of things that you do to alleviate the problem,” she said.
But she does hope that the CBD industry will eventually regulate the way that dosage is worked out to make it easier for consumers.
“Figuring out the right dosage is the worst thing, especially if you are new to it,” she added.
“You do tend to find one bottle and stick to it because you get used to the system. I know they need to declare what is in the bottle but it’s not put out clearly. It doesn’t make it any easier to compare one week to another what strength you are taking.”
The difference in her pain levels has been incredible, Caoimhe says, noticing it most when she took her first holiday since the beginning of the pandemic.
“Two years ago, going on holiday would have been difficult because I would have to carry my own luggage, and would struggle going up and down the steps of the plane. This time I was able to put the case up by myself over the seats. I suddenly realised I had been able to do that and walk up all the steps without any pain,” she added.
“That was something that really shocked me because we hadn’t done anything like that since Covid. I had been in my normal routine and not really noticed it.”
Caoimhe lives in a rural part of Ireland, but thankfully access to CBD has not been an issue. The town she is closest to has many health food stores that stock Irish CBD products. She says she would consider trying medical cannabis for the pain if it increases over time, but with the restrictions concerning chronic pain through Ireland’s MCAP program, this is not currently an option.
“I was taking medication from the doctor for years that was doing my liver absolutely no good, THC is a natural, herbal thing,” she said.
“I would have taken CBD for either condition, but I was lucky that it worked for both. I was able to come off the medication from my doctor as a result.
“I haven’t taken beta-blockers or anti-inflammatories in a couple of years, not since I’ve been taking the CBD.”
Medical cannabis reduces pain and opioid use in cancer patients – study
Findings suggest that medicinal cannabis can be carefully considered as an alternative to the pain relief medicines.
Medical cannabis reduces cancer-related pain and the need for opiate-based painkillers, reveals a new study in oncology patients.
A comprehensive assessment of the benefits of medical cannabis for cancer-related pain, has found that for most oncology patients, pain measures improved significantly, other cancer-related symptoms also decreased, the consumption of painkillers was reduced, and the side effects were minimal.
Published in Frontiers in Pain Research, these findings suggest that medicinal cannabis can be carefully considered as an alternative to the pain relief medicines that are usually prescribed to cancer patients.
Pain, along with depression, anxiety, and insomnia, are some of the most fundamental causes of oncology patient’s disability and suffering while undergoing treatment therapies, and may even lead to worsened prognosis.
Author, David Meiri, assistant professor at the Technion Israel Institute of Technology, explained: “Traditionally, cancer-related pain is mainly treated by opioid analgesics, but most oncologists perceive opioid treatment as hazardous, so alternative therapies are required.
“Our study is the first to assess the possible benefits of medical cannabis for cancer-related pain in oncology patients; gathering information from the start of treatment, and with repeated follow-ups for an extended period of time, to get a thorough analysis of its effectiveness.”
Need for alternative treatment
After talking to several cancer patients, who were looking for alternative options for pain and symptom relief, the researchers were keen to thoroughly test the potential benefits of medicinal cannabis.
“We encountered numerous cancer patients who asked us whether medical cannabis treatment can benefit their health,” said co-author Gil Bar-Sela, associate professor at the Ha’Emek Medical Center Afula.
“Our initial review of existing research revealed that actually not much was known regarding its effectiveness, particularly for the treatment of cancer-related pain, and of what was known, most findings were inconclusive.”
The researchers recruited certified oncologists who were able to issue a medical cannabis license to their cancer patients. These oncologists referred interested patients to the study and reported on their disease characteristics.
Bar-Sela said: “Patients completed anonymous questionnaires before starting treatment, and again at several time points during the following six months. We gathered data on a number of factors, including pain measures, analgesics consumption, cancer symptom burden, sexual problems, and side effects.”
An analysis of the data revealed that many of the outcome measures improved, with less pain and cancer symptoms. Importantly, the use of opioid and other pain analgesics decreased.
In fact, almost half of the patients studied stopped all analgesic medications following six months of medicinal cannabis treatment.
“Medical cannabis has been suggested as a possible remedy for appetite loss, however, most patients in this study still lost weight. As a substantial portion were diagnosed with progressive cancer, a weight decline is expected with disease progression,” reported Meiri.
He continued: “Interestingly, we found that sexual function improved for most men but worsened for most women.”
Meiri would like future studies to dig deeper and look at the effectiveness of medicinal cannabis in different groups of cancer patients.
“Although our study was very comprehensive and presented additional perspectives on medical cannabis, the sex, age, and ethnicity, as well as cancer types and the stage of the cancer meant the variety of patients in our study was wide-ranging. Therefore, future studies should investigate the level of effectiveness of medicinal cannabis in specific subgroups of cancer patients with more shared characteristics.”
Lack of research preventing wider prescribing of cannabis for arthritis
The review found limited progress in understanding the potential of cannabis for the treatment of pain.
A lack of research is preventing wider uptake of medical cannabis prescribing for arthritis pain, according to a new review published in the US.
A new review article has found that there has been limited progress in understanding the potential of cannabis-based therapies for the treatment of pain associated with rheumatic conditions in the past five years.
The article concluded that this is primarily due to a lack of standardisation of clinical research and barriers to conducting research due to existing federal and state regulations in the US.
The review, which was published by CreakyJoints, an international digital community for arthritis patients and caregivers, found that the legalisation and decriminalisation of cannabis at a state level in the US reflects changing attitudes about cannabis as use of the drug increases across a broad range of conditions, including rheumatic diseases.
Unfortunately, while there is strong preclinical evidence showing that cannabis-based products play a role in alleviating pain and reducing inflammation, the highly variable state and federal statutes have limited patient-centred prospective research, education of clinicians and comfort of patients in disclosing their cannabis use to clinicians.
W. Benjamin Nowell, PhD, director of patient-Centered research at CreakyJoints said: “In 2019, CreakyJoints presented data from our ArthritisPower Research Registry study showing more than half of arthritis patients reported wanting information on or actually had tried cannabis and/or cannabidiol products for a purpose they perceived as medical – often for pain relief and help sleeping.
“Yet, three years later, there’s been virtually no advancement in the research necessary to provide clinical evidence that rheumatologists and patients need to make decisions about cannabis use for symptom relief in combination with approved treatments.”
He added: “Without this research, it is impossible to develop clinical guidelines for medicinal cannabis in the US, which is vital for patients seeking the full range of treatment options to explore in partnership with their physicians. The best way to treat rheumatic conditions is through the use of US Food and Drug Administration approved medications, which are backed by evidence demonstrating their effectiveness and safety profile.”
Only three cannabis-based medications are approved by the US Food and Drug Administration, none of which are for the treatment of pain or other symptoms related to rheumatic conditions.
Lack of research stymying uptake of medical cannabis
Researchers draw attention to an array of studies that have shown that cannabinoids are effective in the laboratory at decreasing inflammation in cells and reducing inflammation and pain in mice and rats.
In addition, studies in humans that support efficacy are primarily surveys of people using medicinal marijuana who report relief of pain. However, in rheumatic diseases, there are very few studies of cannabis-based therapies in humans and the clinical trials conducted to date have small sample sizes and inconsistent methods.
“Although the clinical evidence about cannabis for rheumatic disease pain is lacking, it is nevertheless important to educate patients about the known benefits and risks of alternative treatments, including medical cannabis,” said Dr Stuart Silverman, rheumatologist, clinical professor of medicine, Cedars-Sinai Medical Center and UCLA School of Medicine and medical director, OMC Clinical Research Center.
“As a rheumatologist who treats patients with pain, I am aware that some of my patients have found cannabis to be an effective option when traditional medications fail to reduce their pain.
“I am open to discussing medical cannabis when patients express an interest in its use. Then, if they choose to use it, I follow them closely to monitor efficacy and any side effects and to ensure that they do not consider it as a replacement for FDA-approved disease-modifying drugs.”
CreakyJoints recommends that rheumatologists and healthcare providers be prepared to “discuss medicinal cannabis with their patients in an empathetic, non-biased manner”.
Study shows safety of using cannabis with opioids
Findings suggest that CBD and THC are safe for use with opioid pain medication.
Researchers in the US have found that using cannabis with opioids does not increase the risk of addiction.
Findings from a new study suggest that CBD and THC might be safe for use with opioid pain medication, without increasing the risk of addiction.
Although more studies are needed, the results suggest that these compounds, found in cannabis, might be a low-risk way to reduce the dose of opioids needed to relieve pain.
The results show that CBD and THC do not enhance the rewarding effects of opioids, meaning that these compounds may not increase the risk for addiction when used in conjunction with opioid medications.
In the new study, the researchers gave rhesus monkeys the opportunity to choose a food reward or an injection of the opioid fentanyl.
They then tested whether CBD, THC or mixtures containing both compounds affected the number of times monkeys selected fentanyl over food.
They found that a wide range of doses of CBD or THC both alone or in a mixture did not increase or decrease the number of times they selected fentanyl.
Medical cannabis is often cited as an alternative pain reliever to opioid medication, with many patients finding they are able to reduce the number of opioids they are taking after being prescribed cannabis.
Lawrence Carey, PhD, a postdoctoral fellow at the University of Texas Health Science Center, San Antonio, said: “There is intense interest in using medical marijuana in patients with chronic pain because compounds in marijuana like CBD and THC may produce pain relief themselves or enhance the pain-relieving effects of opioids.
“This means people could potentially use lower doses of opioids and still get relief from pain. Taking less pain medication could also lead to a lowered risk of addiction or physical dependence to opioids.”
He continued: “Giving the animals the opportunity to choose between a drug injection and a food reward helped us to somewhat replicate choices a human drug user may face, such as whether to spend money on drugs or food.
“Having the option of responding for food is also useful for studying drugs like THC that produce sedative effects. It helps demonstrate the animal is reallocating behaviour from drug to food choice instead of simply shutting down response for a drug due to sedation.”
The researchers are now conducting other studies to assess whether CBD and THC can decrease signs of opioid withdrawal and relapse.
“A big reason why people continue to take opioids after they become addicted is the appearance of withdrawal symptoms,” said Carey.
“We are using what we learned from this study to determine whether these doses — which didn’t alter choice for food or drug rewards — may help relieve opioid withdrawal or decrease relapse and drug seeking behavior following periods of abstinence.”
The researchers caution that opioid use disorder is a complex disease and there are many factors to consider when developing a drug to treat it.
Although this study indicates that THC and CBD do not increase the rewarding effects of opioids, they say that before applying these findings to people, it will be necessary to determine whether these treatments alter other pathological processes involved with opioid use and to better understand any risks that may be associated with their use.
- How THC and CBD work together in the brain – new study
- Four of the best CBD transdermal products
- Grow Pharma launches new low-priced flower range for UK patients
- New grant funds for “life changing” medical cannabis prescriptions in Jersey
- Research to shed light on how UK clinicians view medical cannabis
- Why patients in Europe are accessing medical cannabis
- News2 years ago
Community extends support to cannabis icon Rick Simpson
- News2 years ago
Cancer survivor claims cannabis oil helped her beat brain tumour
- Case Studies2 years ago
CBD oil and fibromyalgia – a case study
- News2 years ago
NHS lines up cannabis medicine manufacturing
- News2 years ago
Living with chronic fatigue – my CBD story
- News1 year ago
UK grants second licence to grow high-THC medical cannabis
- Insight2 years ago
I’ve gone from a wheelchair to walking thanks to cannabis
- Feature2 years ago
Medical cannabis could help long-term effects of COVID-19, says David Nutt